Morgan Stanley C4 Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,326,134 shares of CCCC stock, worth $8.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,326,134

Previous 1,137,938 104.42%

Holding current value

$8.82 Million

Previous $5.26 Million 152.2%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.43 - $7.38 $5.26 Million - $8.77 Million	1,188,196 Added 104.42%	2,326,134 $13.3 Million
Q2 2024 Oct 17, 2024	BUY	$4.05 - $8.1 $2.53 Million - $5.05 Million	623,755 Added 121.31%	1,137,938 $5.26 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $8.1 $2.53 Million - $5.05 Million	623,755 Added 121.31%	1,137,938 $5.26 Million
Q1 2024 Oct 17, 2024	SELL	$5.3 - $11.0 $3.31 Million - $6.86 Million	-623,755 Reduced 54.81%	514,183 $4.2 Million
Q1 2024 Aug 16, 2024	BUY	$5.3 - $11.0 $1.64 Million - $3.4 Million	308,842 Added 150.4%	514,183 $4.2 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $11.0 $1.64 Million - $3.4 Million	308,842 Added 150.4%	514,183 $4.2 Million
Q4 2023 Aug 16, 2024	SELL	$1.18 - $6.03 $1.1 Million - $5.62 Million	-932,597 Reduced 81.95%	205,341 $1.16 Million
Q4 2023 Feb 13, 2024	SELL	$1.18 - $6.03 $127,128 - $649,648	-107,736 Reduced 34.41%	205,341 $1.16 Million
Q3 2023 Nov 15, 2023	BUY	$1.81 - $3.89 $130,388 - $280,227	72,038 Added 29.89%	313,077 $582,000
Q2 2023 Aug 14, 2023	SELL	$2.75 - $3.77 $146,022 - $200,183	-53,099 Reduced 18.05%	241,039 $662,000
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $263,689 - $767,250	-85,061 Reduced 22.43%	294,138 $923,000
Q4 2022 Feb 14, 2023	BUY	$5.42 - $10.24 $188,681 - $356,474	34,812 Added 10.11%	379,199 $2.24 Million
Q3 2022 Nov 14, 2022	SELL	$8.03 - $12.77 $891,884 - $1.42 Million	-111,069 Reduced 24.39%	344,387 $3.02 Million
Q2 2022 Oct 27, 2022	SELL	$5.06 - $26.46 $1.02 Million - $5.35 Million	-202,116 Reduced 30.74%	455,456 $3.43 Million
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $1.02 Million - $5.35 Million	-202,116 Reduced 30.74%	455,456 $3.43 Million
Q1 2022 Oct 27, 2022	BUY	$19.99 - $33.23 $4.04 Million - $6.72 Million	202,116 Added 44.38%	657,572 $16 Million
Q1 2022 May 13, 2022	SELL	$19.99 - $33.23 $5.22 Million - $8.67 Million	-260,898 Reduced 28.41%	657,572 $16 Million
Q4 2021 Feb 14, 2022	BUY	$29.39 - $46.86 $18.5 Million - $29.4 Million	628,374 Added 216.61%	918,470 $29.6 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $10.4 Million - $14.6 Million	290,096 New	290,096 $13 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $185M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account